Table 1.

Summary of characteristics of patients with B-ALL

Code Assigned	Gender	Age at Diagnosis	FAB Classification	Immunophenotypical Classification	Karyotype	Risk Group	MRD	Treatment Outcome
P1	M	3	L1	Common	Absence of metaphases	LR	_	CR
P2	F	3	L1	Pre-B	Absence of metaphases	LR	_	CR
P3	F	5	L1	Common	56,XX,+X,+4,+6,+8,+10,+11,+14,+17,+21,+mar/46,XX	LR	_	CR
P4	M	2	L1	Common	46,XY	LR	_	CR
P5	F	2	L1	Common	46,XX	LR	_	CR
P6	F	3	L1	Common	54,XX,+X,+6,+15,+15,+17,+18,+21,+21/46,XX	LR	_	CR
P7	F	5	L1	Common	47,XY,+21 c	LR	_	CR
P8	M	6	L1	Common	Absence of metaphases	LR	_	CR
P9	F	5	L1	Pre-B	46, XX	LR	_	CR
P10	M	3	L1	Pre-B	46,XY	LR	_	CR

Code: Internal register assigned for the study; M Male, F Female, LR Low Risk, MRD Minimum Residual Disease, CR Complete remission